Found: 37
Select item for more details and to access through your institution.
Oncogenic EML4-ALK assemblies suppress growth factor perception and modulate drug tolerance.
- Published in:
- Nature Communications, 2024, v. 15, n. 1, p. 1, doi. 10.1038/s41467-024-53451-7
- By:
- Publication type:
- Article
Emerging Targeted Therapies for the Treatment of Non-small Cell Lung Cancer.
- Published in:
- Current Oncology Reports, 2019, v. 21, n. 3, p. N.PAG, doi. 10.1007/s11912-019-0770-x
- By:
- Publication type:
- Article
Identification of a Ras GTPase-activating protein regulated by receptor-mediated Ca<sup>2+</sup> oscillations.
- Published in:
- EMBO Journal, 2004, v. 23, n. 8, p. 1749, doi. 10.1038/sj.emboj.7600197
- By:
- Publication type:
- Article
Mechanisms of Resistance to Epidermal Growth Factor Receptor Inhibitors and Novel Therapeutic Strategies to Overcome Resistance in NSCLC Patients.
- Published in:
- Chemotherapy Research & Practice, 2012, p. 1, doi. 10.1155/2012/817297
- By:
- Publication type:
- Article
The Hippo effector YAP promotes resistance to RAF- and MEK-targeted cancer therapies.
- Published in:
- Nature Genetics, 2015, v. 47, n. 3, p. 250, doi. 10.1038/ng.3218
- By:
- Publication type:
- Article
Rap1 up-regulation and activation on plasma membrane regulates T cell adhesion.
- Published in:
- Journal of Cell Biology, 2004, v. 164, n. 3, p. 461, doi. 10.1083/jcb.200311093
- By:
- Publication type:
- Article
Personalized, Precision Lung Cancer Medicine through Integrated Genomic Analysis.
- Published in:
- Journal of OncoPathology, 2014, v. 2, n. 2, p. 43, doi. 10.13032/tjop.2052-5931.100083
- By:
- Publication type:
- Article
Pathologic Complete Response to Neoadjuvant Crizotinib in a Lung Adenocarcinoma Patient With a MET Exon 14 Skipping Mutation.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Neoadjuvant Oncogene-Targeted Therapy in Early Stage Non-Small-Cell Lung Cancer as a Strategy to Improve Clinical Outcome and Identify Early Mechanisms of Resistance.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Novel computational method for predicting polytherapy switching strategies to overcome tumor heterogeneity and evolution.
- Published in:
- Scientific Reports, 2017, p. 44206, doi. 10.1038/srep44206
- By:
- Publication type:
- Article
Targeting AXL in NSCLC.
- Published in:
- Lung Cancer: Targets & Therapy, 2021, v. 12, p. 67, doi. 10.2147/LCTT.S305484
- By:
- Publication type:
- Article
AXL receptor tyrosine kinase as a therapeutic target in NSCLC.
- Published in:
- Lung Cancer: Targets & Therapy, 2015, v. 6, p. 27, doi. 10.2147/LCTT.S60438
- By:
- Publication type:
- Article
AUY922 Effectively Overcomes MET- and AXL-Mediated Resistance to EGFR-TKI in Lung Cancer Cells.
- Published in:
- PLoS ONE, 2015, v. 10, n. 3, p. 1, doi. 10.1371/journal.pone.0119832
- By:
- Publication type:
- Article
Long Non-Coding RNAs as Emerging Targets in Lung Cancer.
- Published in:
- Cancers, 2023, v. 15, n. 12, p. 3135, doi. 10.3390/cancers15123135
- By:
- Publication type:
- Article
Quantitative Framework for Bench-to-Bedside Cancer Research.
- Published in:
- Cancers, 2022, v. 14, n. 21, p. 5254, doi. 10.3390/cancers14215254
- By:
- Publication type:
- Article
Targeting Oncogenic BRAF: Past, Present, and Future.
- Published in:
- Cancers, 2019, v. 11, n. 8, p. 1197, doi. 10.3390/cancers11081197
- By:
- Publication type:
- Article
Non-Canonical Thinking for Targeting ALK-Fusion Onco-Proteins in Lung Cancer.
- Published in:
- Cancers, 2017, v. 9, n. 12, p. 164, doi. 10.3390/cancers9120164
- By:
- Publication type:
- Article
Digital multiplexed analysis of circular RNAs in FFPE and fresh non-small cell lung cancer specimens.
- Published in:
- Molecular Oncology, 2022, v. 16, n. 12, p. 2367, doi. 10.1002/1878-0261.13182
- By:
- Publication type:
- Article
DDX56 modulates post-transcriptional Wnt signaling through miRNAs and is associated with early recurrence in squamous cell lung carcinoma.
- Published in:
- Molecular Cancer, 2021, v. 20, n. 1, p. 1, doi. 10.1186/s12943-021-01403-w
- By:
- Publication type:
- Article
FAS and NF-κB signalling modulate dependence of lung cancers on mutant EGFR.
- Published in:
- Nature, 2011, v. 471, n. 7339, p. 523, doi. 10.1038/nature09870
- By:
- Publication type:
- Article
Betacellulin drives therapy resistance in glioblastoma.
- Published in:
- Neuro-Oncology, 2020, v. 22, n. 4, p. 457, doi. 10.1093/neuonc/noz206
- By:
- Publication type:
- Article
CIC-DUX4 oncoprotein drives sarcoma metastasis and tumorigenesis via distinct regulatory programs.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Membranes as messengers in T cell adhesion signaling.
- Published in:
- Nature Immunology, 2004, v. 5, n. 4, p. 363, doi. 10.1038/ni1057
- By:
- Publication type:
- Article
Current Landscape of Targeted Therapy in Lung Cancer.
- Published in:
- Clinical Pharmacology & Therapeutics, 2017, v. 102, n. 5, p. 757, doi. 10.1002/cpt.810
- By:
- Publication type:
- Article
Primary and metastatic tumors exhibit systems-level differences in dependence on mitochondrial respiratory function.
- Published in:
- PLoS Biology, 2022, v. 20, n. 9, p. 1, doi. 10.1371/journal.pbio.3001753
- By:
- Publication type:
- Article
Phospholipase C? activates Ras on the Golgi apparatus by means of RasGRP1.
- Published in:
- Nature, 2003, v. 424, n. 6949, p. 694, doi. 10.1038/nature01806
- By:
- Publication type:
- Article
Simultaneous evolutionary expansion and constraint of genomic heterogeneity in multifocal lung cancer.
- Published in:
- Nature Communications, 2017, v. 8, n. 1, p. 1, doi. 10.1038/s41467-017-00963-0
- By:
- Publication type:
- Article
Convergent Akt activation drives acquired EGFR inhibitor resistance in lung cancer.
- Published in:
- Nature Communications, 2017, v. 8, n. 1, p. 1, doi. 10.1038/s41467-017-00450-6
- By:
- Publication type:
- Article
Activating Mutations Cluster in the 'Molecular Brake' Regions of Protein Kinases and Do Not Associate with Conserved or Catalytic Residues.
- Published in:
- Human Mutation, 2014, v. 35, n. 3, p. 318, doi. 10.1002/humu.22493
- By:
- Publication type:
- Article
3-Phosphoinositide-dependent kinase 1 drives acquired resistance to osimertinib.
- Published in:
- Communications Biology, 2023, v. 6, n. 1, p. 1, doi. 10.1038/s42003-023-04889-w
- By:
- Publication type:
- Article
Author Correction: 3-Phosphoinositide-dependent kinase 1 drives acquired resistance to osimertinib.
- Published in:
- Communications Biology, 2023, v. 6, n. 1, p. 1, doi. 10.1038/s42003-023-04979-9
- By:
- Publication type:
- Article
3-Phosphoinositide-dependent kinase 1 drives acquired resistance to osimertinib.
- Published in:
- Communications Biology, 2023, v. 6, n. 1, p. 1, doi. 10.1038/s42003-023-04889-w
- By:
- Publication type:
- Article
A Case of Metastatic Atypical Neuroendocrine Tumor with ALK Translocation and Diffuse Brain Metastases.
- Published in:
- Oncologist, 2017, v. 22, n. 7, p. 768, doi. 10.1634/theoncologist.2017-0054
- By:
- Publication type:
- Article
Small-molecule targeted therapies induce dependence on DNA double-strand break repair in residual tumor cells.
- Published in:
- Science Translational Medicine, 2022, v. 14, n. 638, p. 1, doi. 10.1126/scitranslmed.abc7480
- By:
- Publication type:
- Article
3-Phosphoinositide-dependent kinase 1 drives acquired resistance to osimertinib.
- Published in:
- Communications Biology, 2023, v. 6, n. 1, p. 1, doi. 10.1038/s42003-023-04889-w
- By:
- Publication type:
- Article
Co-activation of STAT3 and YES-Associated Protein 1 (YAP1) Pathway in EGFR-Mutant NSCLC.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Functional screening identifies aryl hydrocarbon receptor as suppressor of lung cancer metastasis.
- Published in:
- Oncogenesis, 2020, v. 9, n. 11, p. 1, doi. 10.1038/s41389-020-00286-8
- By:
- Publication type:
- Article